Stenotrophomonas maltophilia infections: Current status on first-line therapy and other treatment options
Charoenlap N, Poomchuchit S, Mongkolsuk S, Vattanaviboon P
Acta Microbiol Immunol Hung. 2026. doi:10.1556/030.2026.02883
To find the 2nd edition, type "2nd edition"
Stenotrophomonas maltophilia infections: Current status on first-line therapy and other treatment options
Charoenlap N, Poomchuchit S, Mongkolsuk S, Vattanaviboon P
Acta Microbiol Immunol Hung. 2026. doi:10.1556/030.2026.02883
Acquired resistance in Stenotrophomonas maltophilia: Mechanisms underlying the shift from multidrug to pandrug resistance
Vattanaviboon P, Dulyayangkul P, Tipanyo P, Mongkolsuk S, Charoenlap N
Eur J Microbiol Immunol (Bp). 2026;16(1):40-52.
Molecular characterization of pandrug-, extensively drug-, and multidrug-resistant Stenotrophomonas maltophilia isolates from Thailand
Dulyayangkul P, Vanitshavit V, Tipanyo P, Whangsuk W, Bhinija K, Charoenlap N, Mongkolsuk S, Vattanaviboon P
Microb Drug Resist. 2026;32(4):101-110.
A quantitative decision-support framework for assessing the feasibility and sensitivity of wastewater-based epidemiology of respiratory virus surveillance
Samantarat S, Sirikanchana K, Poovorawan Y, Sangsanont J
Int J Hyg Environ Health. 2026;273:114765.
Tracking environmental resistance through surveillance of ESBL- and colistin-resistant Escherichia coli in livestock waste for One Health action
Srathongneam T, Zam P, Paisantham P, Dulyayangkul P, Sresung M, Theplhar S, Charoenlap N, Vattanaviboon P, Kijpreedaborisuthi O, Susutthi S, Mongkolsuk S, Sirikanchana K
Int J Hyg Environ Health. 2026;273:114763.